Does BENDROFLUMETHIAZIDE Cause Cutaneous vasculitis? 18 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Cutaneous vasculitis have been filed in association with BENDROFLUMETHIAZIDE. This represents 1.8% of all adverse event reports for BENDROFLUMETHIAZIDE.
18
Reports of Cutaneous vasculitis with BENDROFLUMETHIAZIDE
1.8%
of all BENDROFLUMETHIAZIDE reports
0
Deaths
18
Hospitalizations
How Dangerous Is Cutaneous vasculitis From BENDROFLUMETHIAZIDE?
Of the 18 reports, 18 (100.0%) required hospitalization, and 18 (100.0%) were considered life-threatening.
Is Cutaneous vasculitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BENDROFLUMETHIAZIDE. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does BENDROFLUMETHIAZIDE Cause?
Hyponatraemia (332)
Acute kidney injury (192)
Confusional state (127)
Hypotension (101)
Vomiting (71)
Dizziness (64)
Hypokalaemia (64)
Fall (60)
Malaise (58)
Agitation (57)
What Other Drugs Cause Cutaneous vasculitis?
METHOTREXATE (207)
ADALIMUMAB (193)
TOCILIZUMAB (161)
ETANERCEPT (148)
APIXABAN (131)
HYDROXYCHLOROQUINE (125)
LEFLUNOMIDE (116)
ABATACEPT (112)
ANAKINRA (112)
INFLIXIMAB (108)
Which BENDROFLUMETHIAZIDE Alternatives Have Lower Cutaneous vasculitis Risk?
BENDROFLUMETHIAZIDE vs BENIDIPINE
BENDROFLUMETHIAZIDE vs BENLYSTA
BENDROFLUMETHIAZIDE vs BENRALIZUMAB
BENDROFLUMETHIAZIDE vs BENSERAZIDE
BENDROFLUMETHIAZIDE vs BENSERAZIDE\LEVODOPA